Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Effects of dulaglutide on endothelial progenitor cells and arterial elasticity in patients with type 2 diabetes mellitus

Fig. 1

Effects of two different treatment regimens on EPCs. Representative fluorescence activating cell sorter (FACS) plots illustrating the identification of EPCs at the 0 week and after 12 weeks in a representative patient in the MET group (A) and the MET-DUL group (B). MET metformin monotherapy group; MET-DUL metformin combined with dulaglutide treatment group

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840